Healthcare / Medical Care FacilitiesJakarta
$320.00
-8.00 (-2.44%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-24.0B · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
40/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$5.49T
P/E
278.3x
↑EV/EBITDA
30.5x
↑ROE
0.8%
↑Gross Margin
29.7%
↓Debt/Equity
0.26
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+10.1%
FCF CAGR
—
FCF margin
-0.4%
FCF / Net income
-0.28x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.86T · net income $30.08B · FCF $-8.30B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1861.97B | $1861.97B | $1706.38B | $1531.66B | $1393.54B |
| Net Income | $30.08B | $30.08B | $11.85B | $12.25B | $4.35B |
| EBITDA | $206.91B | $206.91B | $191.10B | $170.96B | $155.79B |
| EPS | 1.75 | 1.75 | 0.69 | 0.71 | 0.25 |
| Gross Margin | 29.7% | 29.7% | 30.1% | 30.0% | 34.2% |
| Operating Margin | 6.2% | 6.2% | 5.5% | 2.1% | 2.0% |
| Net Margin | 1.6% | 1.6% | 0.7% | 0.8% | 0.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.26 | 0.26 | 0.26 | 0.26 | 0.20 |
| Current Ratio | 0.54 | 0.54 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-8.30B | $-8.30B | $-23.99B | $-379.37B | $-79.30B |
| Returns | |||||
| ROE | 0.8% | 0.8% | 0.3% | 0.3% | 0.1% |
| Valuation | |||||
| P/E | 278.26 | 278.26 | 382.61 | 442.25 | 1144.00 |
| EV/EBITDA | 30.53 | 30.53 | 27.99 | 36.36 | 34.27 |
| P/B | 1.44 | 1.44 | 1.20 | 1.48 | 1.35 |
| Growth & Yield | |||||
| Revenue Growth | 9.1% | 9.1% | 11.4% | 9.9% | — |
| EPS Growth | 153.6% | 153.6% | -2.8% | 184.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
153.2%
EPS terminal req.
$28.39
Spread vs growth
0.5%
5Y implied EPS CAGR
81.4%
EPS terminal req.
$34.36
Spread vs growth
72.2%
10Y implied EPS CAGR
41.3%
EPS terminal req.
$55.33
Spread vs growth
112.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+14.3%
Start / end P/E
405.8x → 182.9x
EPS bridge
0.69 → 1.75
Residual
-84.4%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.